PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $66,300 | -13.0% | 30,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $76,200 | +35.8% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $56,100 | -52.9% | 30,000 | -35.1% | 0.00% | -50.0% |
| Q3 2022 | $119,000 | +32.2% | 46,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $90,000 | -34.8% | 46,200 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $138,000 | -11.5% | 46,200 | +33.1% | 0.01% | +25.0% |
| Q4 2021 | $156,000 | -21.2% | 34,700 | -14.7% | 0.00% | -33.3% |
| Q3 2021 | $198,000 | +1.0% | 40,700 | +42.3% | 0.01% | 0.0% |
| Q2 2021 | $196,000 | +415.8% | 28,600 | +142.4% | 0.01% | +100.0% |
| Q1 2020 | $38,000 | -50.0% | 11,800 | -37.2% | 0.00% | -50.0% |
| Q4 2019 | $76,000 | +24.6% | 18,800 | +33.3% | 0.01% | 0.0% |
| Q3 2019 | $61,000 | -12.9% | 14,100 | +8.5% | 0.01% | -33.3% |
| Q1 2019 | $70,000 | +4.5% | 13,000 | 0.0% | 0.01% | -10.0% |
| Q4 2018 | $67,000 | -42.7% | 13,000 | +8.3% | 0.01% | -28.6% |
| Q3 2018 | $117,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |